GEMAYEL GEORGES
Insider CIK 1256088 · RPTP Director · MNTA Director · SUPN Director · DMTX Director · GMTX See Remarks, Director · NPSP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 6,212 | — | $0 | 6,212 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2026-03-06 | 2026-03-09 | 7,905 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2026-03-06 | 2026-03-09 | 7,905 | $25.30 | $200.0K | 36,064 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-09 | 8,787 | $53.00 | $465.7K | 27,277 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2026-03-05 | 2026-03-09 | 10,000 | $53.71 | $537.1K | 28,159 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 38,159 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2026-02-23 | 2026-02-25 | 15,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2026-02-23 | 2026-02-25 | 15,000 | $12.98 | $194.7K | 33,684 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 4,977 | — | $0 | 4,977 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 2,989 | — | $0 | 2,989 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-09-16 | 2025-09-18 | 1,000 | — | $0 | 1,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 18,684 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 7,296 | — | $0 | 7,296 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 4,475 | — | $0 | 4,475 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2024-11-08 | 2024-11-12 | 10,787 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-11-08 | 2024-11-12 | 10,787 | $36.30 | $391.6K | 13,315 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2024-11-08 | 2024-11-12 | 10,787 | $11.46 | $123.6K | 24,102 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2024-11-07 | 2024-11-08 | 14,213 | — | $0 | 10,787 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-11-07 | 2024-11-08 | 14,213 | $36.62 | $520.5K | 13,315 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2024-11-07 | 2024-11-08 | 14,213 | $11.46 | $162.9K | 27,528 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2024-09-13 | 2024-09-17 | 10,000 | — | $0 | 25,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-09-13 | 2024-09-17 | 10,000 | $31.33 | $313.3K | 13,315 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2024-09-13 | 2024-09-17 | 10,000 | $11.46 | $114.6K | 23,315 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-09-13 | 2024-09-17 | 3,886 | $31.33 | $121.7K | 13,315 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 17,201 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 8,252 | — | $0 | 8,252 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 5,369 | — | $0 | 5,369 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 7,136 | — | $0 | 7,136 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 6,293 | — | $0 | 6,293 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 3,886 | — | $0 | 3,886 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 13,315 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 3,882 | — | $0 | 3,882 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 6,847 | — | $0 | 6,847 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 9,433 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 793,274 | — | $0 | 793,274 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-11-15 | 2021-11-16 | 23,514 | — | $0 | 23,514 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-11-15 | 2021-11-16 | 17,245 | — | $0 | 17,245 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-04-29 | 2021-05-03 | 45,466 | — | $0 | 45,466 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 4,222 | — | $0 | 4,222 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 7,365 | — | $0 | 7,365 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 8,855 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 10,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 11,207 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2020-10-01 | 2020-10-01 | 14,090 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-08-05 | 2020-08-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-08-05 | 2020-08-07 | 10,000 | $14.84 | $148.4K | 24,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-08-05 | 2020-08-07 | 10,000 | $33.00 | $330.0K | 14,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-07-29 | 2020-07-30 | 10,000 | — | $0 | 20,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-07-29 | 2020-07-30 | 10,000 | $30.00 | $300.0K | 14,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-07-29 | 2020-07-30 | 10,000 | $14.84 | $148.4K | 24,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-06-23 | 2020-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-02-21 | 2020-02-25 | 9,305 | — | $0 | 9,305 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2020-02-21 | 2020-02-25 | 5,211 | $23.99 | $125.0K | 5,211 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 14,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2019-02-22 | 2019-02-26 | 12,427 | — | $0 | 12,427 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 4,356 | — | $0 | 4,356 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 8,855 | — | $0 | 8,855 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 9,734 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2018-02-23 | 2018-02-27 | 8,613 | — | $0 | 8,613 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 44,474 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 11,207 | — | $0 | 11,207 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-06-13 | 2017-06-15 | 6,036 | — | $0 | 6,036 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-02-24 | 2017-02-27 | 7,905 | — | $0 | 7,905 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 7,915 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer | 2016-10-25 | 2016-10-26 | 8,330 | $9.00 | $75.0K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | U Tender | 2016-10-24 | 2016-10-26 | 2,092 | $9.00 | $18.8K | 8,330 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-06-23 | 2016-06-27 | 8,330 | — | $0 | 10,422 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2016-04-15 | 2016-04-19 | 7,915 | — | $0 | 7,915 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-04-15 | 2016-04-19 | 2,092 | — | $0 | 2,092 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2016-01-01 | 2016-01-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-23 | 2015-03-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 56,500 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 5,624 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,816 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 9,000 | $46.00 | $414.0K | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 3,816 | — | $0 | 3,816 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2015-01-15 | 2015-01-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 15,188 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 15,188 | — | $0 | 15,188 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-02-13 | 2014-02-14 | 6,188 | $37.70 | $233.3K | 9,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 4,572 | — | $0 | 4,572 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 15,188 | — | $0 | 15,188 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-01-15 | 2013-01-17 | 1,639 | — | $0 | 5,624 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-10-15 | 2012-10-17 | 1,472 | — | $0 | 3,985 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-07-16 | 2012-07-16 | 1,676 | — | $0 | 2,513 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-04-16 | 2012-04-18 | 837 | — | $0 | 837 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-02-28 | 2012-03-01 | 56,500 | — | $0 | 56,500 | SEC↗ |